ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0003 (2.56%)
Apr 25, 2025, 4:00 PM EDT

ViaDerma Company Description

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States.

It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas.

The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.

It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management.

The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014.

ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

ViaDerma, Inc.
Country United States
Founded 2007
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 75
CEO Christopher Otiko

Contact Details

Address:
4640 Admiralty Way
Marina del Rey, Nevada 90292
United States
Phone 310 496 5744
Website viaderma.com

Stock Details

Ticker Symbol VDRM
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US92555K1016
SIC Code 2834

Key Executives

Name Position
Dr. Christopher A Otiko Founder, Chief Executive Officer and President
Qing Hua Lin Chief Financial Officer and Director
Baotang Zhao Chief Sales Officer
Zhang Xie Corporate Secretary and Director
Dr. Andrew Berman M.D., MPH Medical Director and Member of Advisory Board